Pakistan

in page functions
[French]
Pakistan
Total population (2017) 196,743,438
Birth cohort (2017) 5,482,345
Surviving Infants (surviving to 1 year per year, 2017) 5,131,327
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 66/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 81/1000
World Bank Index, IDA (2015) 3.22
Gross Nation Income (per capita US$, 2015) 1,440
Co-financing group (2017) Preparatory transition
No. of districts/territories (2016) 151

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Pakistan

Type of support

Approvals

2001-2021 (US$)
(18 Oct 2017)

Commitments

2001-2021 (US$)
(18 Oct 2017)

Disbursements

2000-2017 (US$)
(18 Oct 2017)

% Disbursed

(18 Oct 2017)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Total $1,016,568,180 $1,135,224,680 $1,022,118,859
Civil Society Organisation support (CSO) $7,638,649 $7,638,649 $7,738,649 101%
Cold Chain Equipment Optimisation Platform (CCEOP) $10,305,181 $10,305,181
Health system strengthening (HSS 1) $23,524,500 $23,524,500 $23,524,500 100%
Health system strengthening (HSS 2) $59,000,000 $84,000,000 $59,000,000 100%
HepB mono (NVS) $24,953,324 $24,953,324 $24,953,324 100%
Immunisation services support (ISS) $48,763,740 $48,763,740 $48,763,740 100%
Injection Safety Devices (NVS) $1,702,500 $3,100,000 $1,972,240 116%
Injection safety support (INS) $7,405,082 $7,405,082 $7,405,082 100%
IPV (NVS) $11,271,043 $11,271,043 $10,950,480 97%
Measles SIA (NVS) $10,029,548 $10,029,548 $10,029,548 100%
Measles SIA - Operational costs (OPC) $21,664,500 $21,664,500 $21,664,500 100%
Penta (NVS) $352,875,914 $377,433,914 $364,336,536 103%
Pneumo (NVS) $367,573,418 $415,407,918 $386,844,240 105%
Rotavirus (NVS) $22,856,500 $42,723,000 $10,839,197 47%
Tetra DTP-HepB (NVS) $31,387,734 $31,387,734 $31,387,734 100%
Vaccine Introduction Grant (VIG) $15,616,547 $15,616,547 $12,709,089 81%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Pakistan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 86%
M:F sex ratio at birth (2017) 1.09
Household survey: DTP3 coverage for male (2012) 67.20%
Household survey: DTP3 coverage for female (2012) 63.10%
Household survey: Last DTP3 survey (2012) 78%
% districts achieving > 80% DTP3 coverage (2016) 64%
% districts achieving < 50% DTP3 coverage (2016) 9%
MCV WHO/UNICEF estimates (2016) 61%

Breakdown of support

Non-vaccine support Vaccine support
18% 82%
$180,805,560 $841,313,299

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Pakistan

12 November 2017

PCV vaccine, Lahore, Pakistan

Pneumonia vaccine saves 500,000 lives in world's poorest countries

Over 109 million children in the developing world have now received pneumococcal conjugate vaccine (PCV).

26 October 2017

Malawi MR 2017

24 October 2017

Bangladesh IPV PCV launch 2015

World Polio Day: Gavi's role in polio eradication

24 October marks World Polio Day, when the global community celebrates the immense progress and considers the work ahead to ensure no child suffers from polio again.

close icon

modal window here